Avexa Reports Positive Phase IIb Result
...)--Mar 20, 2007 - Australian biotechnology company avexa (ASX:AVX) today announced highly successful result...esenting greater than 50% of the overall market. avexa Limited is a Melbourne-based biotechnology company...eases which have a significant unmet medical need. avexa has dedicated resources and funding for key projec...Avexa's Apricitabine Clinical Trial Update
...E)--Jul 5, 2007 - Australian biotechnology company avexa (ASX:AVX) announced today the completion of aprici...rom the 24 week blinded phase later this quarter. avexa also reported that apricitabine continues to maint...for HIV," stated Dr. Julian Chick, CEO of Avexa. avexa Limited is a Melbourne-based biotechnology company...Cytopia Letter to Progen Shareholders
...y Phase III program, this time in HIV; The avexa HIV drug development costs are estimated at $155 m...commendation: Shareholders should vote against the avexa merger by voting "NO" for ALL resolutions and, if ...ard is not supporting a share buy-back without the avexa merger, we recommend you vote against all of the r...Progen Concedes Shareholder Requisitioned Meeting
... - persists with high risk, high funding, avexa merger proposal. -- Shareholders denied sing...bination of the two. The merger proposal with avexa Limited (ASX:AVX) only allows for up to a $20 mill...resented at each meeting. Proposed Progen and avexa merger The material submitted by the Progen b...Cytopia and Other Progen Shareholders Maintain Call for Meeting
...oard appears committed to its merger proposal with avexa Limited (ASX: AVX) and a limited share buyback, to...is should be held at the same time any merger with avexa is considered to allow the Progen shareholders to ... Accordingly, the general meeting to consider the avexa merger should be delayed to enable all of the prop...